
St John of God Foundation funding supports promising MS research
The potential of a biomarker for more effective diagnosis and treatment of people with multiple sclerosis will be probed in...
Continue reading
This website may not work correctly in Internet Explorer. We recommend switching to a more secure modern web browser such as Microsoft Edge which is already installed on your computer.
Read the Perron Institute’s media statements here. See some of the Perron Institute’s media coverage here. Watch our videos on the Perron Institute YouTube channel.

The potential of a biomarker for more effective diagnosis and treatment of people with multiple sclerosis will be probed in...

Exploration of previously under-researched aspects of Parkinson’s disease is revealing new clues on what triggers this degenerative brain disorder and...

Passionate palliative care researcher, Professor Samar Aoun, has received the Western Australia 2023 Australian of the Year Award. The Western...

Internationally recognised research leader in end-of-life care and bereavement support, Professor Samar Aoun, has received a Western Australia 2023 Australian...

UWA’s early career science researchers showcased their innovative projects at the 2022 Rising Stars competition, where 21 of UWA’s brightest...

A new perspective on the mechanisms and therapeutic potential of repetitive transcranial magnetic stimulation (rTMS) is explored in a recently published...

Investigating the causes of multiple sclerosis and the potential for improved treatment of this distressing neurological disorder is the research...

The Perron Institute’s popular Hole in One event at the Wembley Golf Course to raise funds for child health research...

Western Australian-led research to understand an apparent link between the Epstein-Barr Virus and multiple sclerosis (MS) has attracted a grant of almost $900,000 from the US-based National Multiple Sclerosis Society. Despite an...

Professors Steve Wilton AO and Sue Fletcher AO have received a major life sciences industry award from Australia’s pre-eminent industry...

The potential for developing molecular therapies for the treatment of Parkinson’s Disease is explored in a recent paper by researchers...

The first clinical trial is underway for a novel neuroprotective drug developed in Western Australia to reduce brain tissue death...
Stay up to date with our latest news and announcements.